We now have a glimpse behind the curtain of how Medicare arrives at so-called maximum fair prices of prescription drugs it ...
Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper ...
The Trump administration’s Centers for Medicare & Medicaid Services (CMS) has signaled that it will be revamping the process ...
CMS recently issued a statement saying that it's continuing the Medicare Drug Price Negotiation Program but is leaving the door open for potential changes. Experts weighed in on what changes could be ...
If big pharma was hoping that there would not be drug price negotiations under President Trump, they seem to have had their hopes dashed. That ...
In what appears to be a response to manufacturer complaints regarding “black box” Inflation Reduction Act (IRA) drug price negotiations, the ...
Explore how Medicare drug price negotiations under the Inflation Reduction Act could evolve with the Trump administration.
Novo Nordisk's CEO is not worried about blockbuster semaglutide drugs being added to Medicare drug pricing negotiations this ...
The IRA measure is a good first step, but some are looking even further ahead to GLP-1 price drops to increase access.
President Trump will continue to pursue the policy of Medicare pricing negotiation introduced by former President Biden's ...
President Donald Trump is executing a shock and awe strategy, burying the public in a smoky cloud of flamboyant proposals.